5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | SELL | SELL | SELL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.91▲ | 1.92▲ | 1.92▲ | 2.04▼ | 2.03▼ |
MA10 | 1.91▲ | 1.93▲ | 1.95▼ | 2.07▼ | 1.83▲ |
MA20 | 1.92▲ | 1.96▼ | 2.00▼ | 2.02▼ | 1.49▲ |
MA50 | 1.94▲ | 2.04▼ | 2.08▼ | 1.71▲ | 1.98▼ |
MA100 | 1.98▼ | 2.08▼ | 2.07▼ | 1.45▲ | 2.97▼ |
MA200 | 2.06▼ | 2.07▼ | 1.86▲ | 1.61▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.004▲ | 0.001▲ | -0.006▼ | -0.033▼ | 0.123▲ |
RSI | 55.481▲ | 39.701▼ | 38.048▼ | 50.233▲ | 54.443▲ |
STOCH | 38.492 | 35.474 | 23.154 | 38.226 | 76.511 |
WILL %R | 0.000▲ | -50.000 | -72.973 | -90.000▼ | -28.125 |
CCI | 104.965▲ | -38.029 | -71.515 | -148.469▼ | 65.447 |
▼ BREAK | $ZURA Price Breaks 10 Days Low | Set Alert |
Wednesday, August 20, 2025 04:30 AM
HENDERSON, Nev.--(BUSINESS WIRE)-- Zura Bio Limited (Nasdaq: ZURA) (“Zura Bio” or the “Company”), a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for ...
|
Thursday, August 14, 2025 01:15 AM
Zura Bio Limited (Nasdaq: ZURA) (“Zura Bio” or the “Company”), a clinical-stage, multi-asset immunology company dedicated to developing novel dual-pathway antibodies for autoimmune and inflammatory ...
|
Wednesday, August 13, 2025 10:15 PM
Initiated TibuSHIELD, a global Phase 2 clinical study evaluating tibulizumab in adults with moderate to severe hidradenitis suppurativa (HS) in Q2 2025 Continued progress in the Phase 2 TibuSURE ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/09/25 | 2.00 | 2.0393 | 1.88 | 1.92 | 336,839 |
12/09/25 | 2.05 | 2.09 | 1.965 | 2.00 | 255,270 |
11/09/25 | 2.08 | 2.19 | 1.9949 | 2.02 | 293,179 |
10/09/25 | 2.16 | 2.18 | 2.0503 | 2.06 | 332,947 |
09/09/25 | 2.24 | 2.28 | 2.105 | 2.20 | 210,878 |
08/09/25 | 2.19 | 2.24 | 2.15 | 2.21 | 332,701 |
05/09/25 | 2.08 | 2.21 | 2.0212 | 2.20 | 368,594 |
04/09/25 | 2.03 | 2.0801 | 1.97 | 2.07 | 176,866 |
03/09/25 | 2.04 | 2.1026 | 1.98 | 2.03 | 143,360 |
02/09/25 | 2.01 | 2.10 | 1.9807 | 2.02 | 160,030 |
|
|
||||
|
|
||||
|
|